Skip to main content

Table 2 Meta-analysis of the HIF-1α 1790 G/A polymorphism and cancer association.

From: Hypoxia-inducible factor-1α gene polymorphisms and cancer risk: a meta-analysis

Genetic

contrasts

Group and subgroups

under analysis

Studies

(n)

Q test

P value

Model

seclected

OR

(95% CI)

P

A versus G

Overall

12

<0.00001

Random

1.61 (0.75, 3.45)

0.22

 

Overall in HWE

11

0.0002

Random

1.32 (0.54, 3.24)

0.54

 

Caucasian

9

0.04

Random

3.08 (1.49, 6.36)

0.002

 

Caucasian in HWE

8

0.02

Random

2.15 (0.66, 7.02)

0.20

 

East Asian

2

0.33

Fixed

0.58 (0.24, 1.40)

0.23

 

Female*

5

0.07

Random

0.65 (0.07, 6.05)

0.71

 

Male (prostate cancer)**

2

0.64

Fixed

0.96 (0.49, 1.90)

0.91

 

Breast cancer

2

0.45

Fixed

0.28 (0.08,0.90)

0.03

 

Other cancers

10

0.0004

Random

2.31 (1.12, 4.75)

0.02

 

Other cancers in HWE

9

0.002

Random

1.97 (0.79, 4.90)

0.15

(AA+AG) versus GG

Overall

12

<0.00001

Random

1.56 (0.66, 3.65)

0.31

 

Overall in HWE

11

0.0004

Random

1.25 (0.53, 2.97)

0.61

 

Caucasian

9

0.002

Random

2.60 (1.03, 6.59)

0.04

 

Caucasian in HWE

8

0.004

Random

1.80 (0.50, 6.54)

0.37

 

East Asian

2

0.41

Fixed

0.61 (0.25, 1.51)

0.29

 

Female*

5

0.08

Random

0.68 (0.07, 6.30)

0.74

 

Male (prostate cancer) **

2

0.64

Fixed

0.96 (0.49, 1.90)

0.91

 

Breast cancer

2

0.41

Fixed

0.29 (0.09, 0.97)

0.04

 

Other cancers

10

<0.00001

Random

2.22 (0.95, 5.20)

0.06

 

Other cancers in HWE

9

0.002

Random

1.78 (0.72, 4.43)

0.21

  1. OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.
  2. * Only female specific cancers were included in the female subgroup.
  3. ** All male patients were the patients with prostate cancer